Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report
Abstract The definitive efficacy of anaplastic lymphoma kinase (ALK) inhibitors in ALK positive lung squamous cell carcinoma (sqCC) patients remain unclear. Here, we report a case in which brigatinib had a therapeutic effect on ALK‐positive lung squamous cell carcinoma. The patient in this report wa...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Wiley
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/0971c80435b5462b91fbf1f547730466 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|